SNSA footballer from southern Scotland who played on with stage four cancer has died at the age of 20.
Charlie Watson, from Lochmaben, continued playing for Castle Douglas side Threave Rovers despite his skin cancer diagnosis.
A campaign in his name has raised tens of thousands of pounds for research.
In a post on their fundraising page, his mother Amanda said: “We are beyond proud of the journey our Charlie boy has fought.”
SNSShe said the family was “devastated and absolutely heartbroken”.
“He never understood the impact he had on so many people all over the world,” she added.
“You may not not be here now but you will always be with us.”
Charlie made headlines last year when playing in his club’s Scottish Cup clash with Stranraer despite his diagnosis.
Tens of thousands of pounds have been raised in his name towards cancer research.
His club, Threave Rovers, confirmed his death with “profound sadness”.
“Charlie was more than just a player,” it said in a statement.
“He was an absolute warrior, a pillar of our club, and a true inspiration to all who had the privilege of knowing him.
“His strength, determination, and heart both on and off the pitch defined him, and his loss leaves a void that words cannot fill.”
It said his impact at the club had been “immeasurable”.
“Even after his playing days ended, his absence was deeply felt, as he continued to be a source of friendship, leadership, and unwavering support,” it added.
Queen of the South ‘devastated’
The club pledged to ensure his legacy lived on.
“The entire club is devastated by this loss, but Charlie’s spirit will forever remain a part of us,” it added.
Former team Queen of the South said everyone at the club was “devastated” by the news.
“Charlie was not only a fantastic footballer but, more importantly, a truly remarkable person,” it said in a statement.
“He was hard-working, talented, and well-liked by everyone who had the pleasure of knowing him.
“He fought bravely until the very end and inspired those around him with his courage and determination.”
If you are affected by any of the issues in this article, visit Action Line.
